tiprankstipranks
Trending News
More News >
United Therapeutics Corp. (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Financial Statements

Compare
687 Followers

United Therapeutics Financial Overview

United Therapeutics's market cap is currently $22.52B. The company's EPS TTM is $7.7; its P/E ratio is 18.42; United Therapeutics is scheduled to report earnings on February 25, 2026, and the estimated EPS forecast is $7.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.18B$ 2.88B$ 2.33B$ 1.94B$ 1.69B
Gross Profit$ 2.80B$ 2.57B$ 2.07B$ 1.79B$ 1.56B
Operating Income$ 1.49B$ 1.38B$ 1.18B$ 979.70M$ 555.90M
EBITDA$ 1.82B$ 1.65B$ 1.39B$ 1.04B$ 736.80M
Net Income$ 1.33B$ 1.20B$ 984.80M$ 727.30M$ 475.80M
Balance Sheet
Cash & Short-Term Investments$ 1.56B$ 3.27B$ 2.99B$ 2.84B$ 1.93B
Total Assets$ 7.88B$ 7.36B$ 7.17B$ 6.04B$ 5.17B
Total Debt$ 0.00$ 300.00M$ 700.00M$ 800.00M$ 800.00M
Net Debt$ -1.56B$ -1.40B$ -507.70M$ -161.20M$ -94.80M
Total Liabilities$ 783.80M$ 920.00M$ 1.18B$ 1.25B$ 1.21B
Stockholders' Equity$ 7.10B$ 6.44B$ 5.98B$ 4.80B$ 3.96B
Cash Flow
Free Cash Flow$ 1.04B$ 1.08B$ 747.60M$ 663.70M$ 477.40M
Operating Cash Flow$ 1.56B$ 1.33B$ 978.00M$ 802.50M$ 598.20M
Investing Cash Flow$ -551.30M$ 417.20M$ -719.60M$ -811.50M$ -486.90M
Financing Cash Flow$ -1.15B$ -1.25B$ -11.90M$ 75.40M$ 44.80M
Currency in USD

United Therapeutics Earnings and Revenue History

United Therapeutics Debt to Assets

United Therapeutics Cash Flow

United Therapeutics Forecast EPS vs Actual EPS